Yong Li

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 25

Top Topics

Inflammatory Response

Renal Cell Carcinoma

Lipopolysaccharide Induced

Top Venues

Cell death & disease

Journal of immunology research

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Qi Zhang, Yong Li, Qing Zhu, Tao Xie, Yue Xiao, Feng Zhang, Na Li, Keyu Deng, Hong-Bo Xin, Xuan Huang
TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3. Cell death & disease 15 (5) (2024)
Yingjie Huang, Tao Chen, Ming Jiang, Chenlu Xiong, Chao Mei, Jinping Nie, Qi Zhang, Qing Zhu, Xuan Huang, Xuekang Zhang, Yong Li
E3 ligase TRIM65 alleviates intestinal ischemia/reperfusion injury through inhibition of TOX4-mediated apoptosis. Cell death & disease 15 (1) (2024)
Sisi Wei, Xuan Huang, Qing Zhu, Tao Chen, Yan Zhang, Juan Tian, Tingyu Pan, Lv Zhang, Tao Xie, Qi Zhang, Xian Kuang, Enjun Lei, Yong Li
TRIM65 deficiency alleviates renal fibrosis through NUDT21-mediated alternative polyadenylation. Cell death and differentiation (2024)
Qi Zhang, Yong Li, Qing Zhu, Tao Xie, Yue Xiao, Feng Zhang, Na Li, Keyu Deng, Hong-Bo Xin, Xuan Huang
TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3. Cell death & disease 15 (5) (2024)
Sisi Wei, Meiling Ai, Yuan Zhan, Jieqing Yu, Tao Xie, Qinghua Hu, Yang Fang, Xuan Huang, Yong Li
TRIM14 suppressed the progression of NSCLC via hexosamine biosynthesis pathway. Carcinogenesis (2024)
Sisi Wei, Meiling Ai, Yuan Zhan, Jieqing Yu, Tao Xie, Qinghua Hu, Yang Fang, Xuan Huang, Yong Li
TRIM14 suppressed the progression of NSCLC via hexosamine biosynthesis pathway. Carcinogenesis 45 (5) (2024)
Qi Zhang, Yong Li, Qing Zhu, Tao Xie, Yue Xiao, Feng Zhang, Na Li, Keyu Deng, Hong-Bo Xin, Xuan Huang
TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3. Cell death & disease 15 (5) (2024)
Yingjie Huang, Tao Chen, Ming Jiang, Chenlu Xiong, Chao Mei, Jinping Nie, Qi Zhang, Qing Zhu, Xuan Huang, Xuekang Zhang, Yong Li
E3 ligase TRIM65 alleviates intestinal ischemia/reperfusion injury through inhibition of TOX4-mediated apoptosis. Cell death & disease 15 (1) (2024)
Qi Zhang, Yong Li, Qing Zhu, Tao Xie, Yue Xiao, Feng Zhang, Na Li, Keyu Deng, Hong-Bo Xin, Xuan Huang
TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3. Cell death & disease 15 (5) (2024)
Kangning Li, Tao Xie, Yong Li, Xuan Huang
LncRNAs act as modulators of macrophages within the tumor microenvironment. Carcinogenesis 45 (6) (2024)
Yingjie Huang, Tao Chen, Ming Jiang, Chenlu Xiong, Chao Mei, Jinping Nie, Qi Zhang, Qing Zhu, Xuan Huang, Xuekang Zhang, Yong Li
E3 ligase TRIM65 alleviates intestinal ischemia/reperfusion injury through inhibition of TOX4-mediated apoptosis. Cell death & disease 15 (1) (2024)
Yingjie Huang, Tao Chen, Ming Jiang, Chenlu Xiong, Chao Mei, Jinping Nie, Qi Zhang, Qing Zhu, Xuan Huang, Xuekang Zhang, Yong Li
E3 ligase TRIM65 alleviates intestinal ischemia/reperfusion injury through inhibition of TOX4-mediated apoptosis. Cell death & disease 15 (1) (2024)
Yingjie Huang, Tao Chen, Ming Jiang, Chenlu Xiong, Chao Mei, Jinping Nie, Qi Zhang, Qing Zhu, Xuan Huang, Xuekang Zhang, Yong Li
E3 ligase TRIM65 alleviates intestinal ischemia/reperfusion injury through inhibition of TOX4-mediated apoptosis. Cell death & disease 15 (1) (2024)
Kangning Li, Tao Xie, Yong Li, Xuan Huang
LncRNAs act as modulators of macrophages within the tumor microenvironment. Carcinogenesis 45 (6) (2024)
Sisi Wei, Meiling Ai, Yuan Zhan, Jieqing Yu, Tao Xie, Qinghua Hu, Yang Fang, Xuan Huang, Yong Li
TRIM14 suppressed the progression of NSCLC via hexosamine biosynthesis pathway. Carcinogenesis 45 (5) (2024)
Sisi Wei, Meiling Ai, Yuan Zhan, Jieqing Yu, Tao Xie, Qinghua Hu, Yang Fang, Xuan Huang, Yong Li
TRIM14 suppressed the progression of NSCLC via hexosamine biosynthesis pathway. Carcinogenesis 45 (5) (2024)
Kangning Li, Tao Xie, Yong Li, Xuan Huang
LncRNAs act as modulators of macrophages within the tumor microenvironment. Carcinogenesis (2024)
Chenlu Xiong, Xuan Huang, Shibiao Chen, Yong Li
Role of Extracellular microRNAs in Sepsis-Induced Acute Lung Injury. Journal of immunology research 2023 (2023)
Jianrong Chen, Xianjie Feng, Yong Fu, Yong Li
Role of the tripartite motif-containing (TRIM) family of proteins in insulin resistance and related disorders. Diabetes, obesity & metabolism (2023)
Chenlu Xiong, Xuan Huang, Shibiao Chen, Yong Li
Role of Extracellular microRNAs in Sepsis-Induced Acute Lung Injury. Journal of immunology research 2023 (2023)
Chenlu Xiong, Xuan Huang, Shibiao Chen, Yong Li
Role of Extracellular microRNAs in Sepsis-Induced Acute Lung Injury. Journal of immunology research 2023 (2023)
Chenlu Xiong, Xuan Huang, Shibiao Chen, Yong Li
Role of Extracellular microRNAs in Sepsis-Induced Acute Lung Injury. Journal of immunology research 2023 (2023)
Jing Guo, Zhuochen Chen, Yue Xiao, Guiyuan Yu, Yong Li
SATB1 promotes osteogenic differentiation of diabetic rat BMSCs through MAPK signalling activation. Oral diseases (2022)
Yong Li, Qi Zhang, Na Li, Liting Ding, Jinping Yi, Yue Xiao, Shibiao Chen, Xuan Huang
Ataxin-10 Inhibits TNF-α-Induced Endothelial Inflammation via Suppressing Interferon Regulatory Factor-1. Mediators of inflammation 2021 (2021)
Yingjie Huang, Yue Xiao, Xuekang Zhang, Xuan Huang, Yong Li
The Emerging Roles of Tripartite Motif Proteins (TRIMs) in Acute Lung Injury. Journal of immunology research 2021 (2021)